Skip to content

Harmony Biosciences

US · HRMY #2681 by market cap Listed 2020
39.34 -0.02 -0.05%
Live - 5344 symbols - heartbeat 249s ago · 2026-10-08 08:33
Pre-market 39.32 -0.05%
After-hours 39.25 -0.23%
Overnight 38.91 -1.09%
Market cap
2.29B
P/B
2.29
EPS
2.71
Reader sentiment Are you bullish or bearish on HRMY?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Piper Sandler Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Cuts Target Price to $46
    Market Newswire · 2026/4/22
  • Rating change
    Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $44
    Market Newswire · 2026/4/14
  • Wolfe Research Initiates Harmony Biosciences(HRMY.US) With Buy Rating, Announces Target Price $60
    Market Newswire · 2026/8/26
  • Rating change
    Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $45
    Market Newswire · 2026/5/8
  • Rating change
    Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $44
    Market Newswire · 2026/2/24
  • Rating change
    A Quick Look at Today's Ratings for Harmony Biosciences(HRMY.US), With a Forecast Between $30 to $55
    Market Newswire · 2026/8/5
  • Rating change
    Mizuho Securities Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $51
    Market Newswire · 2026/7/31
  • Rating change
    Oppenheimer Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Raises Target Price to $72
    Market Newswire · 2026/4/22
  • Rating change
    Mizuho Securities Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/7/28
  • Deutsche Bank Maintains Harmony Biosciences(HRMY.US) With Hold Rating, Raises Target Price to $39
    Market Newswire · 2026/8/5
  • Rating change
    H.C. Wainwright Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/8/12
  • Rating change
    Deutsche Bank Maintains Harmony Biosciences(HRMY.US) With Hold Rating, Raises Target Price to $36
    Market Newswire · 2026/6/30
  • Deutsche Bank Maintains Harmony Biosciences(HRMY.US) With Hold Rating, Raises Target Price to $42
    Market Newswire · 2026/10/1
  • Rating change
    Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $45
    Market Newswire · 2026/7/16
  • Needham Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/9/24
  • Mizuho Securities Maintains Harmony Biosciences(HRMY.US) With Buy Rating, Maintains Target Price $51
    Market Newswire · 2026/9/26
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Harmony Biosciences Holdings (HRMY) and Adlai Nortye Ltd. Sponsored ADR (ANL)
    TipRanks · 2026/7/16
  • Rating change
    Goldman Sachs Upgrades Harmony Biosciences(HRMY.US) to Hold Rating, Raises Target Price to $37
    Market Newswire · 2026/7/17
  • Rating change
    A Quick Look at Today's Ratings for Harmony Biosciences(HRMY.US), With a Forecast Between $30 to $62
    Market Newswire · 2026/2/26
  • Rating change
    Truist Financial Maintains Harmony Biosciences(HRMY.US) With Hold Rating
    Market Newswire · 2026/2/24

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:33:53 · For reference only, not investment advice and not tailored to your situation.